CD8A and neoplasm: For Chinese LUSC patients, low tumor mutation burden (TMB) and high CD8+ tumor infiltrating lymphocytes (TILs) density were independently associated with longer disease-free survival (DFS), which presented remarkable correlation between the TIME and LUSC8.